Privia Health stock: Q3 results set for November 5
Published on 10/30/2026 at 02:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSWhat Investors Are Watching Next
- Privia Health is scheduled to release third-quarter 2026 results before the market opens.
- MarketBeat reports a generally positive analyst consensus, while the company describes its physician-enablement platform as focused on coordinated, value-based care.
Privia Health Group is scheduled to report its third-quarter 2026 results before the market opens, according to a MarketBeat analysis published on October 29, 2026. The company's investor-relations website separately lists the quarterly report and conference call for November 5, confirming the upcoming reporting event.
Estimates Set the Near-Term Focus
MarketBeat cites analyst expectations of adjusted earnings of USD 0.0906 per share and revenue of USD 610.72 million for the quarter. Those figures are estimates rather than reported results, so the key question for investors will be whether Privia converts its physician-network growth and value-based care activity into earnings that meet or exceed expectations.
The publication also notes that the previous quarter produced earnings of USD 0.19 per share against a consensus estimate of USD 0.07. Revenue reached USD 632.63 million, an increase of 21.4 percent year over year, according to the same report. These prior-period figures provide context for the coming release but do not establish the outcome of the third quarter.
Analyst View Remains Constructive
MarketBeat says 11 analysts rate the company Buy and three rate it Hold, producing a Moderate Buy consensus and an average target of USD 31.00. Such ratings reflect analysts' expectations and should be assessed alongside execution risks, valuation and cash generation rather than treated as a guaranteed share-price outcome.
Privia describes itself as a physician-enablement company that supports independent medical practices with technology, administrative services, payer contracting and population-health programs. Its investor-relations site reports more than 5,600 providers, over 1,300 practice locations and more than 6.1 million patients, with the figures presented as current company profile metrics.
Privia Health Group at a Glance
- Ticker: PRVA
- Listing: Nasdaq
- Upcoming report: Third-quarter 2026 results before market open on November 5, 2026
- Analyst consensus cited by MarketBeat: Moderate Buy
- Average target cited by MarketBeat: USD 31.00
Healthcare investors should also monitor the broader US market backdrop when interpreting any response to the report. Current market reports provide wider market context without implying that index moves caused any change in PRVA.
For additional company-specific coverage, see More news and analyses on Privia Health stock.
MarketBeat is the source for the analyst estimates and consensus information, while Privia Health investor relations provides the company's reporting schedule and business profile.
